List of insiders holdings for Cullinan Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GADICKE ANSBERT Former Director Director 10% Owner | 2023-02-10 16:26:45 | 595,489 7,648,268 | 8,243,757 | Form 5 |
| UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner | 2021-08-25 19:42:33 | 7,805,483 0 | 7,805,483 | Form 4 |
| UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner | 2021-09-20 17:31:24 | 7,648,268 0 | 7,648,268 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2024-11-14 16:24:39 | 5,796,433 0 | 5,796,433 | Form 13G |
| Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner | 2024-02-14 16:59:56 | 2,177,461 0 | 2,177,461 | Form 13G |
| F2 Bioscience I 2017 Ltd Jovan-Embiricos Morana 10% Owner | 2024-02-14 16:59:56 | 2,177,461 0 | 2,177,461 | Form 13G |
| F2 Vision SCS Jovan-Embiricos Morana 10% Owner | 2024-02-14 16:59:56 | 2,177,461 0 | 2,177,461 | Form 13G |
| AHMED NADIM President and CEO | 2024-02-23 17:00:22 | 591,550 0 | 591,550 | Form 4 |
| Hughes Owen President and CEO | 2021-01-14 17:30:09 | 506,226 0 | 506,226 | Form 4 |
| Baeuerle Patrick Chief Scientific Officer | 2023-02-21 18:53:33 | 153,000 341,434 | 494,434 | Form 4 |
| Savill Corrine Chief Business Officer | 2024-02-23 17:00:50 | 278,490 0 | 278,490 | Form 4 |
| Trigilio Jeffrey Chief Financial Officer | 2024-02-23 17:00:15 | 233,919 0 | 233,919 | Form 4 |
| Nguyen Nate Interim PAO and PFO | 2024-04-02 20:50:22 | 224,000 0 | 224,000 | Form 3 |
| Fenton Mary Kay Chief Financial Officer | 2024-04-30 21:02:10 | 200,000 0 | 200,000 | Form 4 |
| Ebeling Thomas Director | 2024-06-11 18:00:03 | 186,653 0 | 186,653 | Form 4 |
| Zawel Leigh See Remarks | 2022-02-15 16:47:15 | 134,785 0 | 134,785 | Form 4 |
| Wigginton Jon Marc Chief Medical Officer | 2021-01-11 17:32:05 | 116,666 0 | 116,666 | Form 4 |
| Jones Jeffrey Alan Chief Medical Officer | 2024-12-20 17:00:06 | 114,059 0 | 114,059 | Form 4 |
| Michaelson Jennifer Chief Scientific Officer | 2024-12-20 17:00:07 | 99,760 0 | 99,760 | Form 4 |
| SUMER JACQUELYN L Chief Legal Officer | 2024-12-20 17:00:04 | 90,651 0 | 90,651 | Form 4 |
| Keane Raymond T Chief Legal Officer | 2022-02-15 16:48:52 | 69,124 0 | 69,124 | Form 4 |
| Ryan David P. Director | 2024-06-27 19:00:02 | 15,806 0 | 15,806 | Form 4 |
| Martin Anne-Marie Director | 2024-06-27 19:00:04 | 15,806 0 | 15,806 | Form 4 |
| Rosenberg Anthony Director | 2024-06-27 19:00:05 | 15,806 0 | 15,806 | Form 4 |
| Webster Stephen W Director | 2024-06-27 19:00:06 | 15,806 0 | 15,806 | Form 4 |
| Meek David D. Director | 2024-05-16 17:40:08 | 15,618 0 | 15,618 | Form 4 |
| Thistle Mary Director | 2024-08-09 18:00:03 | 0 0 | 0 | Form 3 |